chr16-2500392-C-A

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001199107.2(TBC1D24):​c.1427C>A​(p.Ala476Asp) variant causes a missense change. The variant allele was found at a frequency of 0.000507 in 1,604,640 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0027 ( 2 hom., cov: 33)
Exomes 𝑓: 0.00027 ( 4 hom. )

Consequence

TBC1D24
NM_001199107.2 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 3.85
Variant links:
Genes affected
TBC1D24 (HGNC:29203): (TBC1 domain family member 24) This gene encodes a protein with a conserved domain, referred to as the TBC domain, characteristic of proteins which interact with GTPases. TBC domain proteins may serve as GTPase-activating proteins for a particular group of GTPases, the Rab (Ras-related proteins in brain) small GTPases which are involved in the regulation of membrane trafficking. Mutations in this gene are associated with familial infantile myoclonic epilepsy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004905194).
BP6
Variant 16-2500392-C-A is Benign according to our data. Variant chr16-2500392-C-A is described in ClinVar as [Likely_benign]. Clinvar id is 378706.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00273 (416/152364) while in subpopulation AFR AF= 0.00957 (398/41578). AF 95% confidence interval is 0.0088. There are 2 homozygotes in gnomad4. There are 200 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TBC1D24NM_001199107.2 linkuse as main transcriptc.1427C>A p.Ala476Asp missense_variant 7/8 ENST00000646147.1 NP_001186036.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TBC1D24ENST00000646147.1 linkuse as main transcriptc.1427C>A p.Ala476Asp missense_variant 7/8 NM_001199107.2 ENSP00000494678 A1Q9ULP9-1

Frequencies

GnomAD3 genomes
AF:
0.00273
AC:
415
AN:
152246
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00958
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000720
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00334
GnomAD3 exomes
AF:
0.000634
AC:
142
AN:
223970
Hom.:
0
AF XY:
0.000441
AC XY:
54
AN XY:
122526
show subpopulations
Gnomad AFR exome
AF:
0.00997
Gnomad AMR exome
AF:
0.000360
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000355
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000274
AC:
398
AN:
1452276
Hom.:
4
Cov.:
33
AF XY:
0.000229
AC XY:
165
AN XY:
721590
show subpopulations
Gnomad4 AFR exome
AF:
0.0107
Gnomad4 AMR exome
AF:
0.000363
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000237
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000361
Gnomad4 OTH exome
AF:
0.000317
GnomAD4 genome
AF:
0.00273
AC:
416
AN:
152364
Hom.:
2
Cov.:
33
AF XY:
0.00268
AC XY:
200
AN XY:
74514
show subpopulations
Gnomad4 AFR
AF:
0.00957
Gnomad4 AMR
AF:
0.000719
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00331
Alfa
AF:
0.00143
Hom.:
0
Bravo
AF:
0.00306
ESP6500AA
AF:
0.00917
AC:
38
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000780
AC:
94
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Likely benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsJun 12, 2017- -
Benign, criteria provided, single submitterclinical testingGeneDxApr 02, 2019- -
DOORS syndrome;C0917800:Familial infantile myoclonic epilepsy;C1842531:Rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome;C2829265:Autosomal recessive nonsyndromic hearing loss 86;C3809173:Developmental and epileptic encephalopathy, 16;C3892048:Autosomal dominant nonsyndromic hearing loss 65 Benign:1
Likely benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsAug 06, 2021- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineNov 24, 2014Ala476Asp in exon 7 of TBC1D24: This variant is not expected to have clinical si gnificance because it has been identified in 0.9% (38/4142) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs202216463). -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsFeb 01, 2017This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
TBC1D24-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesJun 26, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Developmental and epileptic encephalopathy, 1;C3892048:Autosomal dominant nonsyndromic hearing loss 65;CN236805:Caused by mutation in the TBC1 domain family, member 24 Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.40
CADD
Benign
16
DANN
Benign
0.97
DEOGEN2
Benign
0.0055
.;T;T;.
Eigen
Benign
-0.17
Eigen_PC
Benign
-0.20
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Benign
0.80
.;.;T;T
MetaRNN
Benign
0.0049
T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.7
.;L;L;.
MutationTaster
Benign
1.0
N;N;N
PrimateAI
Benign
0.44
T
PROVEAN
Benign
-0.63
N;.;N;.
REVEL
Benign
0.13
Sift
Benign
0.049
D;.;D;.
Sift4G
Benign
0.21
T;.;T;T
Polyphen
0.83
P;P;P;P
Vest4
0.30
MVP
0.69
MPC
0.64
ClinPred
0.019
T
GERP RS
3.8
Varity_R
0.15
gMVP
0.49

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs202216463; hg19: chr16-2550393; API